The current Wall Street sell-off has wiped out billions in market value, hammering tech giants, banks, and airlines while ...
Dividend-paying stocks are a traditional defensive play, while healthcare faces fewer trade and economic headwinds than most ...
Celonic Integrates Merck’s Breez Micro-Bioreactor Platform Into Its Process Development Operations
The Breez 2 mL micro-bioreactor platform is a fully automated, functionally closed, and continuous perfusion cell culture ...
A federal judge granted summary judgment in favor of Merck for part of the litigation involving the HPV vaccine, Gardasil.
Shares of Merck & Co. Inc. MRK slipped 1.46% to $93.35 Wednesday, on what proved to be an all-around mixed trading session ...
WASHINGTON — The craic wasn’t all good at the White House Wednesday, as President Trump hosted Irish Prime Minister Micheál ...
Merck's DOR/ISL met primary efficacy and safety goals in two Phase 3 HIV trials. Marketing applications are planned for ...
In the second trial, which was open label, 95.6% of participants who switched to DOR/ISL maintained viral suppression ...
New data from the MK-8591A-051 and MK-8591A-052 trials, both investigating the efficacy and safety of 100-mg doravirine and 0.25-mg islatravir as a once-daily 2-drug regimen for virologically ...
In a decision signed Monday, North Carolina federal judge Kenneth Bell granted Merck’s motion to dismiss the claims of ...
OUSA is an ETF that provides exposure to high-quality U.S. companies that pay regular dividends. The fund tracks the O’Shares ...
According to Judge Kenneth Bell, there is a lack of evidence to conclude that Merck willingly misrepresented the safety of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback